385 related articles for article (PubMed ID: 31787618)
1. Wnt Signaling and Drug Resistance in Cancer.
Zhong Z; Virshup DM
Mol Pharmacol; 2020 Feb; 97(2):72-89. PubMed ID: 31787618
[TBL] [Abstract][Full Text] [Related]
2. Targeting the Wnt/β-catenin signaling pathway in cancer.
Zhang Y; Wang X
J Hematol Oncol; 2020 Dec; 13(1):165. PubMed ID: 33276800
[TBL] [Abstract][Full Text] [Related]
3. Wnt signaling in cancer.
Zhan T; Rindtorff N; Boutros M
Oncogene; 2017 Mar; 36(11):1461-1473. PubMed ID: 27617575
[TBL] [Abstract][Full Text] [Related]
4. Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
Wickström M; Dyberg C; Milosevic J; Einvik C; Calero R; Sveinbjörnsson B; Sandén E; Darabi A; Siesjö P; Kool M; Kogner P; Baryawno N; Johnsen JI
Nat Commun; 2015 Nov; 6():8904. PubMed ID: 26603103
[TBL] [Abstract][Full Text] [Related]
5. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: Cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review).
Katoh M
Int J Oncol; 2017 Nov; 51(5):1357-1369. PubMed ID: 29048660
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic Manipulation of Wnt Signaling and Cancer Stem Cells.
Duchartre Y; Kim YM; Kahn M
Methods Mol Biol; 2017; 1613():463-478. PubMed ID: 28849572
[TBL] [Abstract][Full Text] [Related]
7. Targeting Wnts at the source--new mechanisms, new biomarkers, new drugs.
Madan B; Virshup DM
Mol Cancer Ther; 2015 May; 14(5):1087-94. PubMed ID: 25901018
[TBL] [Abstract][Full Text] [Related]
8. Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics.
Harb J; Lin PJ; Hao J
Curr Oncol Rep; 2019 Feb; 21(2):12. PubMed ID: 30715618
[TBL] [Abstract][Full Text] [Related]
9. The Roles of Secreted Wnt Ligands in Cancer.
Werner J; Boonekamp KE; Zhan T; Boutros M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982422
[TBL] [Abstract][Full Text] [Related]
10. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy.
Song P; Gao Z; Bao Y; Chen L; Huang Y; Liu Y; Dong Q; Wei X
J Hematol Oncol; 2024 Jun; 17(1):46. PubMed ID: 38886806
[TBL] [Abstract][Full Text] [Related]
11. The involvement of noncanonical Wnt signaling in cancers.
Chen Y; Chen Z; Tang Y; Xiao Q
Biomed Pharmacother; 2021 Jan; 133():110946. PubMed ID: 33212376
[TBL] [Abstract][Full Text] [Related]
12. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
[TBL] [Abstract][Full Text] [Related]
13. Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities.
Nusse R; Clevers H
Cell; 2017 Jun; 169(6):985-999. PubMed ID: 28575679
[TBL] [Abstract][Full Text] [Related]
14. Wnt signaling as potential therapeutic target in lung cancer.
Yang J; Chen J; He J; Li J; Shi J; Cho WC; Liu X
Expert Opin Ther Targets; 2016 Aug; 20(8):999-1015. PubMed ID: 26882052
[TBL] [Abstract][Full Text] [Related]
15. Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.
Cui J; Jiang W; Wang S; Wang L; Xie K
Curr Pharm Des; 2012; 18(17):2464-71. PubMed ID: 22372504
[TBL] [Abstract][Full Text] [Related]
16. Targeting the WNT Signaling Pathway in Cancer Therapeutics.
Tai D; Wells K; Arcaroli J; Vanderbilt C; Aisner DL; Messersmith WA; Lieu CH
Oncologist; 2015 Oct; 20(10):1189-98. PubMed ID: 26306903
[TBL] [Abstract][Full Text] [Related]
17. Drug discovery approaches to target Wnt signaling in cancer stem cells.
Curtin JC; Lorenzi MV
Oncotarget; 2010 Nov; 1(7):563-577. PubMed ID: 21317452
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic potency of Wnt signaling antagonists in the pathogenesis of prostate cancer, current status and perspectives.
Pashirzad M; Shafiee M; Khazaei M; Fiuji H; Ryzhikov M; Soleimanpour S; Hesari A; Avan A; Hassanian SM
J Cell Physiol; 2019 Feb; 234(2):1237-1247. PubMed ID: 30191954
[TBL] [Abstract][Full Text] [Related]
19. The Wnt signaling pathway in cancer.
Duchartre Y; Kim YM; Kahn M
Crit Rev Oncol Hematol; 2016 Mar; 99():141-9. PubMed ID: 26775730
[TBL] [Abstract][Full Text] [Related]
20. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
Ayadi M; Bouygues A; Ouaret D; Ferrand N; Chouaib S; Thiery JP; Muchardt C; Sabbah M; Larsen AK
Oncotarget; 2015 Jul; 6(21):18518-33. PubMed ID: 26041882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
